STOCK TITAN

GE HealthCare Technologies Inc. - GEHC STOCK NEWS

Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.

GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.

GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.

Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.

Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.

As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.

Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) will showcase AI-enabled medical devices and digital solutions at the HIMSS Global Health Conference. The company aims to address healthcare challenges by leveraging AI to enhance clinical workflows and precision care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
AI
-
Rhea-AI Summary
GE HealthCare unveils the latest LOGIQ ultrasound portfolio with advanced AI tools and innovative features to enhance precision care for clinicians. The LOGIQ Totus, LOGIQ E10 Series, and LOGIQ Fortis offer comprehensive solutions to address evolving healthcare needs, including AI-powered decision support, wireless flexibility, and third-party application integration. The portfolio aims to optimize care delivery, improve workflow efficiency, and combat radiologist shortages worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
none
-
Rhea-AI Summary
GE HealthCare and Biofourmis collaborate to enhance continuity of care from hospital to home, reducing costs and improving patient satisfaction. The partnership aims to provide innovative care-at-home solutions leveraging AI-guided algorithms and virtual components.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.74%
Tags
none
Rhea-AI Summary
GE HealthCare collaborates with OSF HealthCare and Pointcore to enhance patient care and operational efficiencies, aiming to impact over one million patients. The alliance focuses on technology integration, management services, and precision care in oncology, with a strong emphasis on improving patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
GE HealthCare Technologies Inc. (GEHC) announced the pricing of a secondary underwritten public offering of 13,000,000 shares of its common stock at $82.25 per share. General Electric Company (GE) is expected to exchange the GEHC shares for indebtedness held by Morgan Stanley. The offering, led by top financial institutions, is expected to close on February 21, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
-
Rhea-AI Summary
GE HealthCare Technologies Inc. (Nasdaq: GEHC) has announced a secondary underwritten public offering of 13,000,000 shares of its common stock. The company will not receive any proceeds from the sale, as General Electric Company is expected to exchange the shares for indebtedness held by Morgan Stanley. The offering includes an option for underwriters to purchase additional shares, with major financial institutions serving as lead book-running managers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) announces CFO Jay Saccaro's participation in key investor conferences, providing access to the events for stakeholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.96%
Tags
conferences
-
Rhea-AI Summary
GE HealthCare (GEHC) and MedQuest Associates announced a three-year collaboration to optimize multi-site outpatient imaging networks for success. The partnership aims to provide innovative technologies from GE HealthCare and the infrastructure and resources from MedQuest to deliver excellence in patient care. MedQuest will leverage GE HealthCare's AI-enabled digital capabilities to enhance care delivery and product line development in outpatient imaging. The collaboration is expected to boost operational efficiency, expand access, and improve patient outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
none
-
Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) reported strong financial performance for the fourth quarter and full year 2023, with revenue growth of 5% and 7% year-over-year respectively. The company also provided 2024 financial guidance, demonstrating progress toward medium-term financial targets. However, net income margin and adjusted EBIT margin saw declines compared to the prior year. Cash flow from operating activities and free cash flow also experienced slight decreases. Despite these declines, the company invested over $1 billion in R&D for future growth and made significant strides in innovation and market position through strategic acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.65%
Tags
Rhea-AI Summary
GE HealthCare (Nasdaq: GEHC) reported strong financial performance in the fourth quarter and full year of 2023. Revenue growth was 5% year-over-year in Q4 and 7% for the full year. Net income margin was 7.7% in Q4 and 8% for the full year. Adjusted EBIT margin was 16.1% in Q4 and 15.1% for the full year. Cash flow from operating activities was $1.1 billion in Q4 and $2.1 billion for the full year. The company provided 2024 financial guidance, demonstrating progress toward medium-term financial targets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.65%
Tags

FAQ

What is the current stock price of GE HealthCare Technologies (GEHC)?

The current stock price of GE HealthCare Technologies (GEHC) is $86.93 as of February 4, 2025.

What is the market cap of GE HealthCare Technologies (GEHC)?

The market cap of GE HealthCare Technologies (GEHC) is approximately 40.1B.

What does GE HealthCare Technologies Inc. do?

GE HealthCare Technologies Inc. provides transformative medical technologies, pharmaceutical diagnostics, and digital solutions to improve healthcare access and quality globally.

What are the main business segments of GE HealthCare?

The main business segments are Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

How does GE HealthCare generate most of its revenue?

The company generates the majority of its revenue from the Imaging segment.

What recent advancements has GE HealthCare made?

GE HealthCare has made significant advancements in AI integration within medical imaging, improving diagnostic accuracy and efficiency.

Who are GE HealthCare's partners?

The company collaborates with healthcare providers and research institutions to drive innovation and improve healthcare standards.

How does GE HealthCare ensure compliance?

GE HealthCare adheres to strict regulatory compliance standards and maintains rigorous quality controls across its operations.

What products does GE HealthCare offer?

GE HealthCare offers a range of products, including imaging machines, ultrasound devices, patient monitoring systems, and diagnostic contrast media.

What is GE HealthCare's commitment to the community?

The company engages actively with its community and strives to maintain professional and positive interactions while monitoring public posts and conversations.

How has GE HealthCare performed financially?

GE HealthCare has shown robust financial performance with steady revenue growth, supported by continuous investment in research and development.

What is GE HealthCare's mission?

GE HealthCare is committed to improving patient outcomes and making quality healthcare more accessible and affordable worldwide.
GE HealthCare Technologies Inc.

Nasdaq:GEHC

GEHC Rankings

GEHC Stock Data

40.07B
442.77M
3.09%
84.02%
2.79%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States of America
CHICAGO